Latest Convertible Debt News

Peninsula Energy’s low-pH uranium restart delivered stronger grades but struggled to move enough solution through the Lance wellfields, forcing guidance to be withdrawn and triggering a US$50.1 million impairment. Auditors flagged material uncertainty over the company’s ability to continue as a going concern, despite fresh funding and a reconfirmed CY2027 production target.

PainChek grew recurring revenue, implemented licences and customer sites in FY2026, but its $8.94 million loss and $9.24 million operating cash outflow prompted an explicit going-concern warning from its auditor. The company is now betting that US deployments and a sharper commercial focus can convert market access into cash-generating growth.

NEXTDC is seeking A$1.1 billion from institutional investors through subordinated convertible notes, adding to its funding capacity for an increasingly capital-intensive data centre pipeline. The deal offers a low indicative coupon, but introduces future dilution risk and could create short-term share price pressure through associated hedging activity.

Careteq Limited (ASX: CTQ) reported a $398K net loss for FY26 amid a strategic reset that included selling its Embedded Health Solutions business and repaying all debt. The company now pivots fully to growing its HMR Referrals platform with $3.19 million cash on hand.

Etherstack posted a record $8.5 million in revenue for the first half of 2026, driven by strong project and support income, but statutory profit fell 67% due to front-loaded costs and higher expenses.

Global Health Limited boosted customer receipts by 12.6% to A$9.53 million for FY26, completing its SaaS platform upgrade and cutting cash burn by 30%. The company targets sustained EBITDA profitability and international expansion in FY27.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Excite Technology Services has increased its capital raising target to $3.5 million by issuing an additional 40 million shares at 0.6 cents each, accompanied by free-attaching options exercisable at 1 cent. Part of the new shares will require shareholder approval at the upcoming AGM.

Argent BioPharma has struck a global licensing deal for its CannEpil® epilepsy therapy with Splash Beverage Group, securing US$5.5 million upfront through convertible debt forgiveness and retaining manufacturing and intellectual property rights alongside a 15% royalty on future sales.

Booster Wines Limited has proposed exiting its Hawke’s Bay vineyard and winery leases from the Private Land and Property Portfolio, offering a discounted convertible debt payment amid falling grape demand.

Cann Group Limited has agreed to fully redeem its outstanding convertible notes with Obsidian Global GP, LLC at 100% of face value, foregoing the usual early redemption premium. This move concludes the convertible securities facility established earlier in the year.

MC Mining has locked in nearly US$10 million through convertible promissory notes from its major shareholders, targeting the completion and ramp-up of its flagship Makhado hard coking coal project in South Africa.